Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults

被引:3
|
作者
De Santis, Riccardo
Faggioni, Giovanni [1 ,4 ]
Amoroso, Alessandra [1 ]
Ciammaruconi, Andrea [1 ]
Pomponi, Alice [1 ]
Lia, Maria Stella [1 ]
Amatore, Donatella [1 ]
Molinari, Filippo [1 ]
Petralito, Giancarlo [1 ]
Stefanelli, Paola [2 ]
Rezza, Giovanni [3 ]
Lista, Florigio [1 ]
机构
[1] Army Med Ctr, Sci Dept, Rome, Italy
[2] Ist Super Sanita, Dept Infect Dis, Rome, Italy
[3] Minist Hlth, Hlth Prevent Directorate, Rome, Italy
[4] Army Med Ctr, Sci Dept, Via Santo Stefano Rotondo 4, I-00184 Rome, Italy
关键词
Yellow fever; Vaccine; Immunization; Neutralizing antibodies; DURATION; PROTECTION; CHALLENGE;
D O I
10.1016/j.vaccine.2023.03.022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In accordance with the World Health Organization, one dose of yellow fever vaccine may guarantee protection lifelong in healthy adults. However, relatively little information is still available from ad hoc studies. We evaluated the persistence of neutralizing antibodies, which are considered to be an immune correlate of protection, in a large number of military personnel vaccinated up to 47 years before. Overall, 322 individuals were studied. The median time from vaccination to blood collection for neutralizing antibody evaluation was 9 years, ranging from <1 to 47 years. Of the 322 participants, 319 had neutralizing antibodies (99.1 %). The highest median PRNT50 value was observed in those vaccinated <= 1 year before (median PRNT50 = 320). In conclusion, our study confirms on a larger scale that, in healthy adults, neutralizing antibodies may persist as long as 47 years after a single yellow fever vaccines dose. (c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2761 / 2763
页数:3
相关论文
共 50 条
  • [31] ENCEPHALITIS AFTER YELLOW FEVER VACCINATION
    BEET, EA
    BRITISH MEDICAL JOURNAL, 1955, 1 (JAN22): : 226 - 227
  • [32] Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine
    Ainai, Akira
    Tamura, Shin-ichi
    Suzuki, Tadaki
    Ito, Ryo
    Asanuma, Hideki
    Tanimoto, Takeshi
    Gomi, Yasuyuki
    Manabe, Sadao
    Ishikawa, Toyokazu
    Okuno, Yoshinobu
    Odagiri, Takato
    Tashiro, Masato
    Sata, Tetsutaro
    Kurata, Takeshi
    Hasegawa, Hideki
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (02) : 336 - 344
  • [33] Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination
    Sandberg, John Tyler
    Ols, Sebastian
    Lofling, Marie
    Varnait, Renata
    Lindgren, Gustaf
    Nilsson, Ola
    Rombo, Lars
    Kale, Markus
    Lore, Karin
    Blom, Kim
    Ljunggren, Hans-Gustaf
    Lindgren, Gustaf
    Nilsson, Ola
    Rombo, Lars
    Kale, Markus
    JOURNAL OF IMMUNOLOGY, 2021, 207 (04): : 1033 - 1043
  • [34] REACTIONS TO THE VACCINATION AGAINST YELLOW-FEVER
    PIVETAUD, JP
    RACCURT, CP
    MBAILARA, L
    LEVIGOUROUX, A
    LEBRAS, M
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1986, 79 (5BIS): : 772 - 776
  • [35] Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein
    Hao, Meng
    Zhang, Guanying
    Zhang, Shengnan
    Chen, Zhengshan
    Chi, Xiangyang
    Dong, Yunzhu
    Fan, Pengfei
    Liu, Yujiao
    Chen, Yi
    Song, Xiaohong
    Liu, Shuling
    Yu, Changming
    Li, Jianmin
    Xia, Xianzhu
    VIRUSES-BASEL, 2020, 12 (03):
  • [36] CYTOGENETIC STUDIES IN VIVO AND IN VITRO AFTER VIRUS INFECTIONS AND AFTER YELLOW FEVER VACCINATION
    DEGROUCHY, J
    TUDELA, V
    FEINGOLD, J
    PATHOLOGIE BIOLOGIE, 1967, 15 (19-2): : 879 - +
  • [37] Immunisation against yellow fever - Vaccination and sero-vaccination
    Laigret, J
    LANCET, 1935, 1 : 176 - 177
  • [38] Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection
    Ricciardi, Michael J.
    Rust, Lauren N.
    Pedreno-Lopez, Nuria
    Yusova, Sofiya
    Biswas, Sreya
    Webb, Gabriela M.
    Gonzalez-Nieto, Lucas
    Voigt, Thomas B.
    Louw, Johan J.
    Laurino, Fernanda D.
    DiBello, John R.
    Raue, Hans-Peter
    Barber-Axthelm, Aaron M.
    Chun, Kimberly
    Uttke, Samantha
    Raphael, Lidiane M. S.
    Yrizarry-Medina, Aaron
    Rosen, Brandon C.
    Agnor, Rebecca
    Gao, Lina
    Labriola, Caralyn
    Axthelm, Michael
    Smedley, Jeremy
    Julander, Justin G.
    Bonaldo, Myrna C.
    Walker, Laura M.
    Messaoudi, IIhem
    Slifka, Mark K.
    Burton, Dennis R.
    Kallas, Esper G.
    Sacha, Jonah B.
    Watkins, David I.
    Burwitz, Benjamin J.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (689)
  • [39] Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination
    Stienlauf, S
    Shoresh, M
    Solomon, A
    Lublin-Tennenbaum, T
    Atsmon, Y
    Meirovich, Y
    Katz, E
    VACCINE, 1999, 17 (03) : 201 - 204
  • [40] Detection of Anti-Yellow Fever Virus Immunoglobulin M Antibodies at 3-4 Years Following Yellow Fever Vaccination
    Gibney, Katherine B.
    Edupuganti, Srilatha
    Panella, Amanda J.
    Kosoy, Olga I.
    Delorey, Mark J.
    Lanciotti, Robert S.
    Mulligan, Mark J.
    Fischer, Marc
    Staples, J. Erin
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2012, 87 (06): : 1112 - 1115